MR-Guided Transurethral Ultrasound Ablation (TULSA)-An Emerging Minimally Invasive Treatment Option for Localised Prostate Cancer.
Cardiovasc Intervent Radiol
; 47(6): 689-701, 2024 Jun.
Article
in En
| MEDLINE
| ID: mdl-38491163
ABSTRACT
The optimal treatment strategy for men with localised prostatic cancer of low and intermediate risk is an actively evolving field. It is important to strike a balance between maximal oncological control and minimal treatment-related complications, which helps preserve the patients' quality of life. MR-guided transurethral ultrasound ablation (TULSA) has emerged as a minimally invasive treatment option for this group of patients. This article aims to provide of a background on TULSA technology, a step-by-step procedural guide of MR-guided TULSA and to summarise the current evidence of TULSA in management of localised prostatic cancer, as well as other potential indications.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Magnetic Resonance Imaging, Interventional
Limits:
Humans
/
Male
Language:
En
Journal:
Cardiovasc Intervent Radiol
Year:
2024
Document type:
Article
Affiliation country:
Hong Kong